Influence of the bile acid/microbiota axis in ileal surgery: a systematic review
Colorectal Disease · 2024
DOI: 10.1111/codi.16837 ↗At a glance
Systematische Übersicht in Colorectal Disease, 2024. Written by Tharindu Senanayake and 5 co-authors. Institution: NHMRC Centre of Research Excellence in Digestive Health, New Lambton Heights, New South Wales, Australia. Major MEDLINE topics: Bile Acids and Salts, Gastrointestinal Microbiome, Ileum, Feces. Cited 1 times so far (Crossref); 57 references.
Abstract (original language)
Aim
The gastrointestinal bile acid (BA)/microbiota axis has emerged as a potential mediator of health and disease, particularly in relation to pathologies such as inflammatory bowel disease (IBD) and colorectal cancer. Whilst it presents an exciting new avenue for therapies, it has not yet been characterized in surgical resection of the ileum, where BA reabsorption occurs. The identification of BA/microbiota signatures may provide future therapies with perioperative personalized medicine. In this work we conduct a systematic review with the aim of investigating the microbiome and BA changes that are associated with resection of the ileum.
Method
The databases included were MEDLINE, EMBASE, Web of Science and Cochrane libraries. The outcomes of interest were faecal microbiome and BA signatures after ileal resection.
Results
Of the initial 3106 articles, three studies met the inclusion/exclusion criteria for data extraction. A total of 257 patients (46% surgery, 54% nonsurgery controls) were included in the three studies. Two studies included patients with short bowel syndrome and the other included patients with IBD. Large‐scale microbiota changes were reported. In general, alpha diversity had decreased amongst patients with ileal surgery. Phylum‐level changes included decreased Bacteroidetes and increased Proteobacteria and Fusobacteria in patients with an intestinal resection. Surgery was associated with increased total faecal BAs, cholic acid and chenodeoxycholic acid. There were decreases in deoxycholic acid and glycine and taurine conjugated bile salts. Integrated BA and microbiota data identified correlations with several bacterial families and BA.
Conclusion
The BA/microbiota axis is still a novel area with minimal observational data in surgery. Further mechanistic research is necessary to further explore this and identify its role in improving perioperative outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- NHMRC Centre of Research Excellence in Digestive Health, New Lambton Heights, New South Wales, Australia.
- Surgical and Perioperative Care Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
- School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
- Hunter Medical Research Institute, Immune Health Program, New Lambton Heights, New South Wales, Australia.
ORCID profiles: Tharindu Senanayake, Simon Keely
Cite
APA
Senanayake, T., Makanyengo, S., Hoedt, E. C., Goggins, B., Smith, S. R., & Keely, S. (2024). Influence of the bile acid/microbiota axis in ileal surgery: a systematic review. Colorectal Disease. https://doi.org/10.1111/codi.16837
Vancouver
Senanayake T, Makanyengo S, Hoedt EC, Goggins B, Smith SR, Keely S. Influence of the bile acid/microbiota axis in ileal surgery: a systematic review. Colorectal Disease. 2024. doi:10.1111/codi.16837
BibTeX
@article{Senanayake2024,
author = {Senanayake, Tharindu and Makanyengo, Samwel and Hoedt, Emily C and Goggins, Bridie and Smith, Stephen R and Keely, Simon},
title = {Influence of the bile acid/microbiota axis in ileal surgery: a systematic review},
journal = {Colorectal Disease},
year = {2024},
doi = {10.1111/codi.16837}
}
EUVIMED